|
Deal with GenomeQuest
exchanges access privileges, clinical data for
funding.
By Kevin Davies
Bio-IT World
Feb. 1, 2008
| The Canadian developers of a popular drug database
have partnered with a software company in an unusual
win-win relationship. The deal exchanges short-term
funding that might ensure the long-term survival of
the database in return for exclusive data access to
the commercial partner, GenomeQuest.
Read
More
|
